Working on a CRISPR Cure of Lou Gehrig's Disease

MCB Professor of Neurobiology and of Chemical and Biomolecular Engineering David Schaffer and colleagues "have for the first time used CRISPR-Cas9 gene editing to disable a defective gene that causes amyotrophic lateral sclerosis, or Lou Gehrig's disease, in mice, extending their lifespan by 25 percent."


Photo Credit: David Schaffer